P04.40

Clinical Causes: Maternal consumption of various substances during pregnancy, including opioids, methamphetamines, cocaine, or other drugs of addiction. Unspecified drug use when the specific substances are unknown or not documented. Chronic drug dependence in the mother that persists during pregnancy.

Key Symptoms: Low birth weight Premature birth Respiratory distress or breathing difficulties Hypoglycemia (low blood sugar levels) Feeding difficulties or poor feeding Irritability and excessive crying Seizures Sleep disturbances Jaundice (yellowing of the skin and eyes) Congenital anomalies or birth defects, depending on specific drug exposure

Diagnosis Path: Diagnosis of infants affected by maternal drug use involves a combination of clinical examination, review of maternal history, and laboratory tests. Tests may include urine, blood, or meconium screening of the newborn to detect various substances. Healthcare providers assess the infant for signs of withdrawal (neonatal abstinence syndrome) and other health complications associated with in utero drug exposure. A comprehensive evaluation helps determine the severity of symptoms and guides appropriate management.

Treatment Protocols: Management of newborns affected by maternal drug use focuses on alleviating withdrawal symptoms and providing supportive care. Common interventions include: - Medications to treat withdrawal symptoms, if necessary - Nutritional support and proper feeding techniques - Monitoring vital signs and developmental progress - Ensuring a calm and secure environment to reduce irritability - Early intervention services for developmental support Post-discharge care may involve ongoing monitoring and therapeutic services to promote healthy growth and development. Support for the mother, including substance use treatment and counseling, is also essential for long-term health outcomes.